Skolkovo Foundation Biomed Cluster

Skolkovo resident Infectex has created a brand new drug against tuberculosis

Ronan LeonardMarch 24, 2017

Biotechnology company Infectex (resident of the Skolkovo Foundation Biomed Cluster, a portfolio company of Maxwell Biotech Venture Fund) has announced positive ...

BiotechCutting EdgeFuture TrendsHealthInnovationMedTechWorld News

Podcast

From Cloud to AI: The Growing Need for Dedicated Internet Access Patrick Masterson, MD of Magnet Plus

Day 2 Dublin Tech Summit podcasts

Day 1 Dublin Tech Summit podcasts

Crypto

Stripe builds out the economic infrastructure for AI with 288 launches

What Could Your Wallet Look Like in the Future?

Could Crypto iGaming be a game changer in Ireland?

Business Showcase

Over 100 Women in Business attend Tri-County event to mark International Women’s Day 2026

Business Showcase : Wealth Transfer Token (WTT)

HMD Fusion Revolutionizes Smartphones with Smart Outfits and Detox Mode

Reviews

Leading Beyond Fear: The Formula for Psychological Safety, Adaptability, and Growth, reviewed

The 8 Laws of Employee Experience: How to Build a Future-Ready Organization, reviewed

There’s Nothing Like This: The Strategic Genius of Taylor Swift, reviewed

Cutting Edge

TCS and Anthropic launch Global Premier Partnership to drive Enterprise AI scaling

Off-Grid Solar Reaches Record Sales, Serving Nearly 150 Million People

€40 million call for disruptive innovation, Disruptive Technologies Innovation Fund

Interviews

Has AI Reached Its Ozempic Moment? Insights with Joaquín Cuenca

Day 2 Dublin Tech Summit podcasts

Day 1 Dublin Tech Summit podcasts

Skolkovo Foundation Biomed Cluster

Skolkovo resident Infectex has created a brand new drug against tuberculosis

From Cloud to AI: The Growing Need for Dedicated Internet Access Patrick Masterson, MD of Magnet Plus

Day 2 Dublin Tech Summit podcasts

Day 1 Dublin Tech Summit podcasts

Pin It on Pinterest